Europe’s first stem cell therapy backed by NICE

Chiesi's Holoclar, the first stem-cell therapy to be cleared by European regulators, has received a green light for use on the NHS in England and Wales to treat a rare sight condition.

• Source: pharmatimes
• 878
• August 29, 2017